that involved an unusual multi-resistant E. coli O78:H10 strain. Surprisingly, the isolates qualified as enteroaggregative E. coli (EAEC), a diarrheagenic pathotype, making this the first reported involvement of EAEC in an extraintestinal disease outbreak. Paper IV reports an analysis of 51 archived E. coli O78:H10 isolates (1956 2000) that showed E. coli O78:H10 to be clonally heterogeneous, comprising one dominant clonal group (61% of isolates, including all 19 Copenhagen outbreak isolates) from ST10 (phylogenetic group A), plus several minor clonal groups (phylogenetic groups A and D). The outbreak clone exhibited both extraintestinal pathogenic E. coli (ExPEC) and EAEC characteristics. Paper V reports evidence that the outbreak strain adhered more extensively to human bladder epithelial cells than did prototype uropathogenic (ExPEC) strains thanks to its aggregative adherence fimbriae, the principal adhesins of EAEC, and was capable of extensive biofilm formation on urethral catheters. These findings suggest that certain EAEC-specific virulence factors increase uropathogenicity.
CHAPTER 1. INTRODUCTION
Escherichia coli is a natural part of the microbiome of man and other warm-blooded animals, harbored in the colon as part of the commensal flora that lives in a symbiotic relationship with the host. Thus, animals form a potential reservoir of pathogenic E. coli (1) . These microorganisms cause a wide variety of intestinal and extraintestinal infections. E. coli is the most common agent of urinary tract infection (UTI) and gram-negative bacteremia, associated with both community-onset and healthcare-associated infections.
Herbert John Webber first used the expression "clone" in 1903 (2) to designate a population in which all members have been derived from one and the same progenitor by non-sexual multiplication. In 1983, a workshop on the Clone Concept was held (2) . Here, the word clone was used to denote bacterial isolates recovered independently from different sources, in different geographic locations, and possibly at different times, but showing so many identical phenotypic and genetic traits that they most likely shared a common origin (ancestor). At this time, serotyping, according to the modified Kauffman scheme based on E. coli's O (somatic), H (flagellar), K (capsular) surface antigen, and F (fimbrial) antigens, was available (3) (4) (5) , with a specific combination of the antigens defining the serotype. Biotyping, antibiograms, and plasmid characterization were also available, but new methods were under development. Examinations of enteropathogenic E. coli (EPEC) showed that specific EPEC serotypes, e.g., O111:H2 and O55:H6, were associated with outbreaks and severe disease, as well as with characteristic biotypes and other phenotypic traits (2, 6) . The question was raised at this time as to whether the remaining thousands of E. coli serotypes also belong to globally disseminated clones. A universal consensus definition of clones or clonal groups still does not exist, nor is there a widely accepted definition of strain, subclone, lineage, or sublineage. Authors use these terms variably, with or without defining them in the particular context.
E. coli of specific serotypes are associated with certain clinical syndromes, and thus serotypes serve as readily identifiable markers that correlate with specific virulent clones (5) .
Numerous molecular typing methods have been developed during the last 35 years, whole genome sequencing (WGS) being the latest. Multilocus sequence typing (MLST) revealed that E. coli and many other bacterial species have a clonal structure and that some clones are widespread (7) . Different lineages have split off from a common ancestor of all E. coli, giving rise to four main phylogenetic groups A, B1, B2, and D (8, 9) . Newer sequencebased phylogeny of the species has shown how these have in turn been split up into various clonal groups that can be divided into multiple sublineages (1, (10) (11) (12) . Some sublineages, termed extraintestinal pathogenic E. coli (ExPEC), cause extraintestinal infections such as urinary tract infections, bloodstream infections, neonatal meningitis, and peritonitis. Other lineages represent diarrheagenic E. coli (DEC), whereas others are simply commensal.
The pathogenicity of the individual lineages depends mostly on their virulence gene content. According to one operational definition, ExPEC clonal groups are characterized by presence of ≥ 2 of papA and/or papC (P fimbriae; counted as one), sfa/foc (S and F1C fimbriae), afa/dra (Dr-binding adhesins), kpsM II (group 2 capsule), and iutA (aerobactin system) (13) . An alternative definition is based on presence of ≥ 3 of chuA (heme binding), fyuA (yersiniabactin receptor), vat (vacuolating toxin), and yfcV (putative fimbrial subunit) (14) . E. coli isolates that carry chuA, fyuA, vat, and yfcV efficiently colonize the urinary tract (14) . An example of a widespread multidrugresistant E. coli clonal group among ExPEC's is clonal group A (CGA) from phylogenetic group D (15, 16) . This clonal group, which emerged in the 1990s, is associated with trimethoprim-sulfamethoxazole resistance and is a common cause of various extraintestinal infections. Other examples are the ExPEC clonal groups serotype O15:H52:H1 from phylogenetic group D and ST131 from phylogenetic group B2.
Six major diarrheagenic E. coli (DEC) pathotypes are recognized currently (1, 5, 12) : enteropathogenic E. coli (EPEC), Vero/Shiga toxin-producing E. coli (VTEC/STEC), Shigella/enteroinvasive E. coli (EIEC), enteroaggregative E. coli (EAEC), enterotoxigenic E. coli (ETEC), and diffusely adherent E. coli (DAEC). DEC are also defined by their gene contents, although typical EPEC also are defined by specific serotypes, as mentioned above. VTEC/STEC are defined by the presence of stx1 and/or stx2, encoding Verotoxin/ Shiga toxin 1 and 2. Two examples of clonal groups among STEC are O157:H7, and O26: H11/H-. STEC O157:H7 is an important zoonotic pathogen that causes diarrhea, bloody diarrhea, and hemolytic-uremic syndrome (HUS). STEC O157:H7 can be divided into six lineages, of which several are associated with bovine and human carriage, as well as clinical disease (17) . The other is STEC O26:H11/H-, a highly virulent clone that has emerged recently in several European countries (18) . Another DEC pathotype is EIEC, which is biochemically, genetically, and pathogenetically related closely to Shigella spp.; like Shigella spp., EIEC strains are generally lysine decarboxylase-negative, non-motile, and lactose-negative. EIEC have genes encoding invasion such as ipaH, and share pathogenic, genetic, and biochemical characteristics with Shigella. Strains exhibiting one or more of the genes aggR, aatA, and aaiC (19) are considered to be EAEC. EAEC is a very common diarrheal pathotype, occurring in multiple lineages (20) . Its pathogenic potential is illustrated by volunteer studies, outbreaks, and other epidemiological data (21) (22) (23) . Additionally, the 2011 European outbreak of Shiga toxin-producing EAEC highlights the epidemic potential of EAEC (24) ; however, the pathogenicity and clinical relevance of these bacteria are still controversial (25) . ETEC are defined by having genes encoding heat-stable enterotoxin (ST) and/or heat-labile enterotoxin (LT). DAEC are traditionally defined by the presence of the DA pattern in the HEp-2 adherence assay (26) , and the prototypical strain C1845 is a DAEC strain that encodes Afa/Dr adhesins; however, the implication of intestinal Afa/Dr DAEC in diarrhea is still under debate (27) .
Evolution of E. coli is caused by gene transfer vertically and horizontally. Variable genes, such as plasmids, prophages, and pathogenicity islands (PAIs) (28) make up more than twothirds of the E. coli genome. Continuous gene flux accelerates the adaption of E. coli to different environments, allowing the appearance of multiple gene combinations and new hypervirulent strains, such as the hybrid STEC/EAEC O104:H4 (29, 30) . Numerous E. coli clonal groups and lineages have been described to date, and the number is rising progressively.
In the present thesis, a combination of traditional phenotypic methods and newer molecular typing methods has been used.
The aim of the present thesis was to summarize the history and present knowledge of virulence factors and antimicrobial resistance of four distinctive pathogenic E. coli clonal groups, i.e., O15:K52:H1, O117:K1:H7, O78: H10, and ST131.
CHAPTER 2. METHODS USED IN CHARACTERIZATION AND TYPING OF E. COLI

Phenotypical characterization
Identification -Isolates were confirmed as E. coli by use of a Minibact E kit (31), a b-glucuronidase test using PGUA plates ((32), I, II), and matrix-assisted laser desorption/ionization-time-of-flight (MALDI-TOF) mass spectrometry (Bruker Daltonics), calibrated with the Bruker E. coli bacterial test standard for mass spectrometry (VI). Verotoxin/Shiga toxin was detected by the Verocell assay ((33),  I, II, III, IV, VI, VII) .
Serotyping was done according to Ørskov and Ørskov ((3), I, II, III, IV, VI, VII). K antigens were determined by counter-current immunoelectrophoresis involving K-specific antisera, except for the K1 and K5 antigens, which were detected using K1-and K5-specific phages (I, II, III, IV, VI, VII). Biotyping was done according to Kauffmann ((34) , I, II, III, IV). Hemolysin production was determined on blood agar plates ((35), I, II, III, VI), and aerobactin secretion was determined in a crossfeeding bioassay ((36), I).
Biofilm production was assessed by detection of crystal violet retention after overnight broth growth in polystyrene microtiter plates described in paper VI (V, VI, VII). Biofilm formation under hydrodynamic conditions on size 14 sterile Foley all-silicone catheters (Bard) was assessed as described by Stahlhut et al. with some modifications ((37-39), V). The catheterized bladder model was performed as described by Stahlhut et al. with some modifications ( (38, 40, 41) , V).
Cell adhesion assays -The human larynx cancer-derived epithelial cell line HEp-2, the human bladder cancer-derived epithelial cell line 5637, and the human colon cancer-derived epithelial cell line T84 were used for cell adhesion assays as described in paper V.
Mouse model of ascending urinary tract infection -Single-and co-infection studies using 6 to 8-week-old female OF-1 mice (Charles River Laboratories) were done as described by Struve et al. and Hvidberg et al. ((42, 43) , V).
Antibiotic susceptibility testing was determined either by broth microdilution using the Sensititre system (Trek Diagnostic Systems Ltd., UK) or by disk diffusion tests using Rosco tablets or Oxoid disks (44) . ESBL production was screened for by cefpodoxime resistance and confirmed by the double-disk synergy test, with disks containing cefotaxime and ceftazidime with and without clavulanate (45) .
Genotypical characterization
Molecular typing -Molecular typing was performed on all clonal groups. All isolates in paper I underwent EcoRI riboprinting (automated ribotyping), were manually ribotyped according to the method of Gerner-Smidt (46) , and were subjected to PFGE (47) , which was done according to the PulseNet protocol ((48), II, IV, VI, VII). Pulsotypes were defined at the ≥94% profile similarity level, which corresponds approximately to a ≤ 3-band difference, suggesting genetic relatedness ((49), IV, VI, VII). Selected isolates underwent plasmid analysis by a modification (50) of the method of Kado and Liu ((51) , I, III). Plasmids in E. coli 39R861 (52) and V517 (53) were used as size references.
Virulence genotyping -Isolates were tested for multiple extraintestinal and diarrheagenic virulence genes (Table 1) by two different PCR-based methods (54) . First, 50 virulence markers of ExPEC were detected using established multiplex PCR assays ((55-58), I, IV, VI, VII). Testing was done in duplicate using independently prepared boiled lysates of each isolate, together with appropriate positive and negative controls. Isolates were regarded as ExPEC if positive for ≥ 2 of papA and/or papC (P fimbriae; counted as one), sfa/foc (S and F1C fimbriae), afa/dra (Dr-binding adhesins), kpsM II (group 2 capsule), and iutA (aerobactin system) (13) . The combination "kpsM II-positive, kii-negative" was interpreted as indicative of the K2 or K100 capsule ((59, 60), VII). Virotypes and subtypes thereof were defined by specific gene combinations ((61), VII). The virulence score was the number of extraintestinal virulence genes detected, adjusted for detection of the pap, sfa/foc, and kps operons (I, IV, VI, VII). Second, a multiplex PCR was used to screen for the diarrheagenic enteroaggregative E. coli (EAEC)-associated putative virulence genes aggR, aatA, and aaiC ((19), IV, VI, VII). Strains exhibiting ≥ 1 of these genes were considered to be EAEC (19) . Third, using DNA probe hybridization (I, II) and real-time PCR (IV), isolates were examined for several diarrheaassociated genes, including those encoding the porcine (estA p ) and human (estA h ) variants of Phylogenetic analysis and multilocus sequence typing (MLST) -Classification of major E. coli phylogenetic groups (A, B1, B2, and D) was performed by triplex PCR ((9), I, IV, VI). MLST was performed according to the Achtman scheme ((89), I, IV, VI) using seven housekeeping genes, i.e., adenylate kinase (adk), fumarate hydratase (fumC), DNA gyrase subunit B (gyrB), icd, malate dehydrogenase (mdh), adenylosuccinate dehydrogenase (purA), and ATP/GTP-binding motif (recA). Procedures, primers, and sequence type (ST) assignment were as described at http://mlst. ucc.ie/mlst/dbs/Ecoli.
H30 and H30Rx subclone detection -PCRbased screening was used to classify ST131 isolates into the H30 subclone if they contained H30-specific polymorphisms in fimH (90) , and further into the H30Rx subclone if they also contained an H30Rx-specific polymorphism in the allantoin protein-encoding gene ((91), VII).
Molecular confirmation of O types, O25b and O16, was accomplished by PCR-based detection of the corresponding rfb variants ( (92, 93) , VI). CGA was screened for using a specific PCR, with selective MLST confirmation (55) (VI). ST131 status was determined using real-time PCR (94) and conventional PCR (95) . The presence of O15:K52:H1 clonal group was confirmed by a single-nucleotide polymorphism (SNP)-specific PCR (96) .
The gene encoding CTX-M-15 was detected using a bla CTX-M-15 -specific PCR assay ((54), VI, VII). The presence of other b-lactamase genes was investigated by PCR and nucleotide sequencing using primers specific for bla TEM , bla CTX-M , bla OXA-2 , bla OXA-10 , and bla SHV (97) .
Statistical methods -Comparisons were tested using Fisher's exact test (two-tailed) for proportions (I, IV, VI, VII) and the Mann-Whitney U test for scores (I, IV, VI, VII). Assessments of multiple variables as predictors of an outcome variable were done by multivariable logistic regression analysis or multiple regression (I, VII). Student's t-test was used for statistical evaluation of biofilm production and adherence (V). P-values of <0.05 were considered statistically significant.
Detailed descriptions of the methods are found in the individual papers.
Comparison of selected E. coli typing methodsTyping methods for discriminating different bacterial isolates of the same species are essential epidemiological tools in infection prevention and control (98) . The traditional phenotypic O:K:H serotyping and biotyping is time-consuming, tedious, and expensive (3, 34) . Serotyping is performed reliably only by a small number of reference laboratories in the world, of which The Danish WHO reference laboratory, Statens Serum Institut is one. However, these traditional typing methods have yielded substantial knowledge regarding clones and subclones, and their use in combination with modern molecular methods would probably be valuable for linking older and newer knowledge regarding clones. Identification of ExPEC clonal groups using gene-specific PCR assays based on distinctive SNPs is simple, reproducible, and available to any laboratory. (59, 96, 99) .
Despite PFGE being considered by many researchers as the "gold standard", many strains are not typable by this technique due to the degradation of the DNA during the process (gel smears), as is the case for O15:K52:H1 E. coli clonal group (I). PFGE is relatively inexpensive and well suited to short-term outbreak investigation (IV); however, both MLST (100) and WGS ( (101), VII, present thesis) are superior to PFGE regarding reproducibility, portability, and for revealing the underlying phylogeny of E. coli. WGS offers an expanded set of genes and thus finer resolution than MLST, which is critical for fighting rapid clonal expansions such as ST131 (102) .
Unlike most other reports in the field, this thesis was built uniquely on a combination of traditional phenotypic and modern molecular typing methods, which in some instances revealed unexpected discrepancies between serotyping and PCR, and was helpful in the evaluation of molecular methods. For example, comparison with classic capsular antigen detection showed that the combined PCR result of "kpsM II-positive, kii-negative" was indicative of both the K2 and the K100 capsule ((59, 60), VI). Likewise, among the O15:K52:H1 isolates, which were homogeneous by MLST, biotyping revealed a subset designated biotype C (Raf À, Mal +, Lac À ) that emerged during the 1990s and correlated with multidrug resistance.
Aside from its utility as a discriminatory phenotype, the inability to ferment lactose might be of some pathogenic importance. All members of the O117:K1:H7 and O78:H10 clonal groups were lactose-negative, as were members of biotype C of the O15:K52:H1 clonal group, which compared to other biotypes within this clonal group was associated with diarrhea, estAp, and fluoroquinolone resistance. Likewise, 12/129 (9%) of the historic ST131 isolates were lactose-negative. Notably, compared with lactose-positive ST131 isolates, the lactosenegative ST131 isolates more commonly represented EAEC (6/12 [50%], vs 6/116 [5%]: p < 0.001), and were gentamicin-resistant (9/12 [75%] vs 27/116 [23%]: p < 0.001). Moreover, four urine isolates suspected of being part of an unrecognized ST131 UTI outbreak in Copenhagen in 1998 were also lactose-negative, in contrast to the four concurrent ST131 isolates from Copenhagen from other specimen types, which were all lactose-positive.
CHAPTER 3. THREE-DECADE EPIDEMIOLOGICAL ANALYSIS OF E. COLI O15:K52:H1 (I)
E. coli O15:K52:H1 first came to clinicians' attention as a significant pathogen in 1986-1987 during a yearlong, community-wide outbreak in South London (103) . Most patients in the London outbreak had UTI, but some had septicemia associated with pneumonia, meningitis, or endocarditis; three died. The London outbreak strain exhibited a 100 MDa plasmid and was resistant to ampicillin, chloramphenicol, streptomycin, sulfonamides, tetracycline, and trimethoprim.
At approximately the same time (1986-1990), 17 (5%) of 377 unique E. coli bacteremia isolates from a University hospital in Copenhagen, Denmark, were identified as serotype O15:K52:H1, making this the second most common serotype found (Table 2 ) (104). Eleven (65%) of the 17 Danish O15:K52:H1 isolates originated from patients with UTI.
The 17 Danish strains of serotype O15:K52: H1 were of both nosocomial and communityacquired origin and had similar phenotypic characteristics as the South London E. coli O15:K52:H1 isolates. However, 10 (59%) of these 17 isolates were susceptible to all antibiotics tested, in marked contrast to the multiresistant London outbreak strain.
In response to the Danish paper (104), Dalmau et al. reported in a letter an evaluation of 160 episodes of bacteremia due to E. coli collected in Barcelona, Spain, during a 4-year period (105) . These investigators found that serotype O15:K52:H1 accounted for a similar fraction of bacteremia isolates as in the Danish study, i.e., 4% (7/160), although only serogroup and capsular antigen K1 were examined in their study. All Spanish O15:K52:H1 bacteremia isolates were of urinary tract origin (105) .
In the following years, E. coli O15:K52:H1 was shown to be distributed widely outside Europe, where it exhibited previously unrecognized phenotypic and genotypic diversity (106) ). In an Italian study from 2008 (107), the O15:K52:H1 clonal group accounted for 16 (11%) of 148 fluoroquinolone-resistant isolates from uncomplicated UTIs in eight European countries in 2003-2006, providing evidence of continued clinical importance for this clonal group. In this study, membership in the O15: K52:H1 clonal group was confirmed by a SNP-specific PCR; O and H antigens were examined by specific antisera, while K antigens were not examined. (96) . A similar prevalence was found in a Canadian study from 2009 (95) . Here, three established drug-resistant E. coli clonal groups (CGA, E. coli O15:K52: H1, and ST131) were searched for among 199 (95) . The Canadian O15:K52:H1 isolates were all resistant to fluoroquinolones, and accounted for 19% of all fluoroquinoloneresistant isolates. In paper I, the successful E. coli O15:K52: H1 clonal group served as a case study for the mechanisms of the emergence of widely disseminated, multiresistant pathogens, which are important to understand for public health reasons. This study, which was the largest to date for this pathogen, tested the hypotheses that a possible explanation for this clonal group's emergence was that the O15:K52:H1 clonal group had become increasingly virulent and resistant to antibiotics over time. One hundred archived international E. coli O15:K52:H1 clinical isolates from 100 unique patients were characterized for diverse phenotypic and molecular traits. The clonal group probably emerged clinically in the early 1970s, since the earliest representative isolate in the collection of the international Escherichia and Klebsiella Centre (WHO) was from 1975, with none found from 1951 to 1974. All 100 isolates were from phylogenetic group D, and ST393. They all carried the F16 papA allele and papG allele II (P fimbria structural subunit and adhesin variants), iha (adhesinsiderophore), fimH (type 1 fimbriae), fyuA (yersiniabactin receptor), iutA (aerobactin receptor), and kpsM II (group 2 capsule); 85% to 89% contained a complete copy of the pap operon and ompT (outer membrane protease).
Slight additional virulence profile variation was evident, particularly within a minor diarrhea-associated, lactose-negative subset (biotype C). Two fecal isolates from patients with diarrhea exhibited genes normally found in ETEC, i.e., the porcine (estA p ) and human (estA h ) variants of the heat-stable enterotoxin gene. To our knowledge, these two genes have not previously been detected in typical ExPEC. Biotype C (Lac À ) was particularly interesting because of its statistical association with diarrhea, estA p , and fluoroquinolone resistance. Notably, in the Italian study of fluoroquinolone-resistant isolates (107), the 16 identified O15:K52:H1 clonal group members were all non-lactose-fermenting, like the present biotype C isolates. Biotype C thus may represent an emerging subset within the O15: K52:H1 clonal group that exhibits enhanced fitness for multiple pathogenic niches.
In contrast to the O15:K52:H1 clonal group's fairly stable virulence profile from 1975 to 2006, during the same years, the clonal group's antimicrobial resistance profiles increased by a mean of 2.8 units per decade (p < 0.001), including the new appearance of fluoroquinolone resistance. Moreover, the numbers of virulence genes and resistance markers were positively associated (p = 0.046). At least for this clonal group, this argues against the hypothesis that antimicrobial resistance and virulence are mutually exclusive, which implies that strains give up virulence genes when they become resistant, as has been proposed for fluoroquinolone resistance (108) .
In the period 2007-2015, three Danish and one Japanese O15:H52:H1 isolates were submitted to the WHO reference Centre. One Danish urine isolate (described in paper VI) produced CTX-M-14; one Danish blood isolate and surprisingly two EAEC isolates (one Danish fecal isolate and one Japanese isolate of unknown source). This is the first report of EAEC within the O15:K52:H1 clonal group. We therefore screened all 104 O15:K52:H1 isolates in the WHO Centre for EAEC, but did not find additional EAEC-positive isolates (unpublished data).
In 2010, an Australian study found 33 O15: K52:H1 isolates (5.7%) among 582 ExPEC human clinical isolates, vs. only one isolate (0.8%) among 125 isolates from companion animals (109) , and in 2012 another Australian study reported a canine O15:K52:H1 isolate that closely resembled a human isolate according to all assessed traits (110) . The authors concluded that O15:H52:H1 strains contribute to the fluoroquinolone-resistant ExPEC population in Australia and may potentially be transferred between humans and dogs. This assumption is in accordance with a recent Australian paper describing the role of canine feces as a reservoir of human-associated ExPEC and the potential of E. coli O15:K52:H1 as a canine pathogen (111) . The findings support the hypothesis that companion animals may be colonized with ST354, ST393 (i.e., clonal group O15:K52:H1), and ST457 E. coli with the capacity to cause antimicrobial-resistant extraintestinal infection, almost certainly in dogs and possibly in humans (111).
In conclusion, over time the O15:K52:H1 clonal group has become increasingly resistant to antimicrobials while maintaining or expanding its virulence potential, a particularly concerning trend if other emerging multiresistant enterobacterial clonal groups follow a similar pattern. E. coli O15:K52:H1 continues to spread geographically, and remains a globally distributed, resistance-associated ExPEC clonal group of clinical importance. At the time, microbiology laboratories in only 6 of 16 Danish counties were able to identify STEC in stool specimens from cases of traveler's diarrhea, so the actual number of cases nationally was probably much higher. The main clinical symptoms were persistent watery diarrhea and abdominal cramps, although 2 of 20 subjects were healthy carriers returning from military duty in Eritrea. This is in contrast to the high rate of bloody diarrhea generally seen in STEC O157 infections (112) , but in accordance with a recent Belgian study that found that the presence of stx1 was significantly associated with non-bloody diarrhea and with manifestations other than HUS or diarrhea (p = 0.003) (113) . The median duration of gastrointestinal symptoms among symptomatic patients was 11 weeks; 80% were ill for more than 30 days. Shedding duration, which was known for five patients, exhibited a median of 9 weeks (range, 2-96 weeks). In 19 cases, the infection was acquired during travel to Asia, Africa, or Cuba, whereas the remaining case was laboratory-acquired. By colony dot-blot hybridization, all 20 strains were positive for stx1 and negative for stx2, eae, saa, and ehxA. Thirteen strains (65%) were resistant to four or more antimicrobial agents. By PFGE using the restriction enzyme XbaI, the strains were clonally related, but not indistinguishable.
Few investigations have addressed the duration of shedding of STEC. The duration of shedding of STEC O157 is usually few weeks, but has been described to last up to 124 days (114-118). Pai et al. (116) Both symptoms of clinical infection and shedding of STEC O117:K1:H7 seem to be of much longer duration than described in any other group of STEC (115) (116) (117) (120) (121) (122) . The O117:K1:H7 clonal group thus seems to be an excellent colonizer of the human intestine, despite the absence of the eae and saa genes that are considered to be important adherence factors (5, 123, 124) . Like O117:K1:H7, the German O104:H4 strain lacked eae-encoding intimin, which has been considered to be the key colonization factor of STEC (124) . In contrast, the German STEC O104:H4 strain colonizes humans through aggregative adherence fimbrial pili encoded by the enteroaggregative E. coli plasmid (125) . The Danish O117:K1:H7 strain was not EAEC, but the intimin-like sivH genes might be a factor responsible for its persistent colonization ability (126) , please see below, however, further studies in this area are needed.
Thirteen of the Danish STEC O117:K1:H7 isolates (65%) were resistant to ≥4 antimicrobial agents. Compared with other STEC found at the time (114, (127) (128) (129) , the prevalence of antibiotic resistance in the O117 clonal group is high; however, more extensively resistant STEC strains have been reported, including some with ESBL production (130) (131) (132) .
Four other publications reported a total of five isolates of STEC O117:H7 (133) (134) (135) (136) . Two were reported from Belgium in 1990 and 1997 (133, 134) ; one from Switzerland in 1992 (136) and two isolates were reported from Spain in 1997 from patients with watery diarrhea after traveling in the Indian subcontinent and Central America (135) .
A 2011 report from the Swiss national reference laboratory, described 97 non-O157 human STEC isolates from 2000 to 2009 (137) . These included three (3.1%) O117:H7 strains, with a virulence pattern identical to that of 20 STEC O117:H7 strains reported in Paper II. One of these strains was associated with a patient who traveled to India. Another Belgian report described one O117:K1:H7 stx1 strain found among 206 STEC isolates obtained when 14,705 unique stools were screened in 2008-2010 (113); thus, the prevalence of STEC O117:K1:H1 was 0.007%.
The STEC O117:K1:H7 E. coli clonal group has also been seen in England (126) . During 2004-2013, 19 isolates of STEC O117:K1:H7 were submitted to the Gastrointestinal Bacteria Reference Unit at the Health Protection Agency in London, UK, from laboratories in England and Wales for confirmation of identification and typing. All isolates were originally misidentified by the submitting laboratories as Shigella sonnei or Shigella spp., probably because of their characteristic biochemical phenotype, being negative for the production of lysine decarboxylase and b-galactosidase (ortho-nitrophenol test), like the isolates reported in paper II. The purpose of the English study (138) was to investigate the evolutionary origins, putative virulence genes, and pathoadaptive mechanisms of this STEC serotype. WGS identified genetic mechanisms involved in the pathoadaptive phenotype. Sequencing also identified toxin and putative adherence genes flanked by sequences indicating horizontal gene transfer from Shigella dysenteriae and Salmonella spp., respectively. The authors concluded that the pathogenicity of STEC O117:K1:H7 most likely was multifactorial and the result of a novel combination of the lack of cadA (encoding cadaverine synthesis) and lacZ (encoding b-D-galactosidase) genes and the presence of stx1 and the intiminlike sivH genes, probably demonstrating pathoadaptivity and horizontal gene transfer. (MSM), most of whom were HIV-positive and had multiple sexual partners (139) . The STEC O117:K1:H7 isolates reported in paper II produced only VT1, which is probably why only one patient suffered from bloody diarrhea and no patients developed HUS. A multivariate analysis has indicated that the presence of stx2 and eae, but not stx1 with or without eae, is associated with bloody diarrhea and HUS (140) . Recently, however, a single case of HUS in a patient infected with a stx1-positive isolate has been reported from Ireland (141) .
Three patients reported in paper II received antibiotic treatment with ciprofloxacin for persistent diarrhea, and all were clinically cured without complications. Due to the possibility of the release of Shiga toxin from dying and dead bacterial cells, antibiotic treatment of patients with known or suspected STEC infection is considered problematic because of a potentially increased risk of developing HUS (142) , especially in cases of STEC O157:H7 (143) . Interestingly, a recent Danish systematic review found that only one case of HUS has ever been reported in patients with diarrheal symptoms of more than 14 days (144) . With the purpose of eradicating STEC from the intestine without initiating toxin production and because treatment with protein synthesis inhibitors caused a decrease in Shiga toxin in 12 studies, the authors proposed that antibiotic treatment with protein and cell wall synthesis inhibitors can be considered when specific criteria regarding patient group, serotype, virulence profile, and duration of disease are met. All of these criteria for treatment were met in the three cases of persistent diarrhea caused by STEC O117:K1:H7.
During the last 15 years (2001-2015), STEC O117 comprised on the average 4.5% of all STEC isolates found in Denmark (144), (Fig. 1) . However, as could be expected, STEC O117 contained a much higher fraction of travelers' diarrhea. STEC O117 on the average made up 20% (range, 5-55%) of STEC from travelers' diarrhea in Denmark in 2001-2015 (SSI.dk).
Presently, Public Health England is investigating a rise in E. coli (STEC) O117:H7, possibly connected to MSM (145) . All these findings demonstrate that O117:K1:H7 is a clonal group of STEC that should be considered in patients with persistent watery diarrhea returning from Africa and Asia and among MSM.
CHAPTER 5. ENTEROAGGREGATIVE E. COLI (EAEC) O78:H10 (III, IV, AND V)
A cluster of multiresistant lactose-negative E. coli with a highly unusual serotype, O78: H10 was identified in Greater Copenhagen in 1991-1992 (III). Eighteen patients experienced predominantly community-acquired UTI caused by multiresistant E. coli O78:H10; two of these also suffered from diarrhea. In addition, one AIDS patient with diarrhea was identified. Thirteen patients were predisposed to UTI, one patient had an indwelling urinary catheter and one was treated with intermittent catheterization. Eleven patients showed clinical signs of UTI. Following the outbreak, up until 2015, no further O78:H10 isolates were received at the WHO Escherichia and Klebsiella Centre at Statens Serum Institut (personal communication, Flemming Scheutz).
Serogroups O78:H11 and O78:H12 (146) have been isolated frequently from cases of human enterotoxigenic diarrhea, but this was the first report of O78:H1O causing human disease, and one of the first reports of an outbreak of community-acquired UTI (147) . The phylogenetic origin, clonal background, and virulence characteristics of the outbreak strain and its relationship to 32 archived E. coli non-outbreak O78:H10 strains according to these traits and resistance profiles were characterized in paper IV.
The Copenhagen outbreak isolates clearly represented a single clonal strain within ST10, whereas E. coli serotype O78:H10 overall was shown to be highly clonally diverse. ST10 is the most common ST among E. coli and is known to be present in most human and foodanimal sources (148) . ST10 is pathotypically heterogeneous (20) , comprising EAEC, ETEC (20, 89, 149) , ExPEC, and commensal E. coli (150, 151) . Unexpectedly, 71% of the study isolates, including all 19 outbreak isolates, fulfilled both the molecular criteria and the phenotypic "stacked brick" adherence pattern for the diarrheagenic pathotype EAEC, but not the molecular criteria for ExPEC (13) , despite containing several ExPEC-associated virulence genes (vide infra). This finding contradicts the conventional understanding that E. coli strains causing diarrhea are distinct from those that cause extraintestinal disease, both phylogenetically and according to their discrete repertoires of syndrome-specific virulence genes (58) .
Although the O78:H10 outbreak clonal group did not meet the molecular definition of ExPEC, the urine isolates contained five ExPEC-associated virulence genes (fyuA, iutA, pic, traT, and sat), and a typical outbreak isolate was highly lethal in a mouse model of subcutaneous sepsis. Taken together, these observations suggest that the outbreak clone indeed does represent ExPEC.
Some of the strain's EAEC-associated genes may also contribute to its extraintestinal virulence. EAEC characteristics among UTI E. coli isolates have been reported in several instances (152, 153) , and in vitro assays (154) have demonstrated that EAEC-associated aggregative adherence fimbriae might facilitate uroepithelial cell adherence (155) . Conversely, uropathogenic traits have also been reported among certain EAEC fecal isolates (154, (156) (157) (158) .
A potential food or animal origin has been proposed for certain human-associated, multidrug-resistant uropathogenic E. coli clonal groups (23, 159) , and a close relationship has been demonstrated between E. coli strains from retail chicken meat and those causing human UTI (160). However, no candidate animal source for the Copenhagen outbreak was identified here, despite the search among >10.000 achieved animal/meat isolates in WHO Collaborating Centre for reference and research on Escherichia coli and Klebsiella at the Statens Serum Institut. However, only 10 contemporary strains of E. coli O78 isolated from calf spleens at Statens Veterinaere Serumlaboratorium were analyzed.
This minor cluster of E. coli 078:H1O was only noticed because of its multidrug resistance and inability to ferment lactose. It seems likely that the occurrence of similar clusters of extraintestinal E. coli infections like the O78:10 and O15:K52:H1 clonal groups (103, 161) may not be rare events. This assumption is supported by reports of major pandemic clonal lineages of ExPEC, including ST131 (60, 162), ST393, ST69, ST95, and ST73 (163) , and the evidence for other community outbreaks of UTI (147) .
Whether the E. coli O78:H10 outbreak strain and other EAEC isolates that contain urovirulence genes are both diarrheagenic and extraintestinal pathogenic remains to be determined.
Eleven (58%) of the Copenhagen O78:H10 outbreak isolates were excellent producers of biofilm in a microtiter plate assay. Additionally, in an in vitro catheterized bladder model, one strain (C555-91, wild type), selected as a representative outbreak isolate, was capable of producing extensive biofilm on catheters (V). Deletions of the aggDCBA gene cluster (encoding AAF) or aggR, strikingly attenuated the ability of C555-91 to form biofilm (p = 0.001), revealing that the ability of C555-91 to form a strong biofilm was mediated by AAF fimbriae. Moreover, the AAF/I mutant of strain C555-91 showed >100-fold attenuation in biofilm formation on catheters compared to the wild type in the in vitro model. Of importance, deletion of AAF did not alter the growth rate in the bladder and thus did not affect the number of bacteria transferred from the bladder into the catheter in the model. The C555-91 outbreak strain furthermore exhibited significantly increased adherence to human bladder epithelial cells compared to prototype uropathogenic strains.
The findings in paper V suggest that AAF fimbriae might play a similar role in colonizing human bladder epithelial as in colonizing the intestinal tract (164) and that EAEC-specific virulence factors increase uropathogenicity and may have played a significant role in the ability of the strain to cause a communityacquired outbreak of UTI.
It seems likely that EAEC-associated characteristics contribute to pathogenicity when combined with other virulence factors, such as Shiga toxin (stx2) (138, 164) , and probably also ExPEC virulence factors, as discussed above for E. coli O78:H10, and below for ST131. In some instances, EAEC characteristics may be the specific traits needed to allow a potentially epidemic clonal group, subclone, or strain to cause an outbreak. As such, as many EAEC virulence genes are carried by plasmids, which probably facilitate transfer of genetic material to other bacteria, inclusion of EAEC-specific virulence factors is warranted in future studies of outbreaks of both UTI and diarrheagenic E. coli.
CHAPTER 6. PREVALENCE AND CHARACTERISTICS OF ST131 IN COPENHAGEN AND TEMPORAL TRENDS WITHIN ST131 AND ITS H30 AND H30RX SUBCLONES (VI AND VII)
E. coli ST131, most members of which exhibit serotype O25:H4 is a recently emerged, globally disseminated cause of multidrug-resistant (MDR) extraintestinal infections (165, 166) . ST131 was first reported in 2008, based on isolates from nine countries that spanned three continents (167) (168) (169) . The sudden global emergence was probably associated with travel to and emigration from the Indian subcontinent (170) (171) (172) .
ST131 is closely associated with fluoroquinolone resistance and production of the CTX-M-15 ESBL (91, 173) . CTX-M-type enzymes have become the dominant ESBLs worldwide during the past decade (174) . The responsible bla CTX-M genes are associated with conjugative plasmids and certain successful bacterial clones, notably ST131 (175) .
ST131 was initially considered to be particularly prevalent in community settings (165) , but subsequent findings have suggested otherwise (176) . Paper VI reports a significant association, among recent E. coli clinical isolates in greater Copenhagen, between ST131 and community acquisition; thus, 40/44 (91%) ST131 isolates vs 53/71 (75%) non-ST131 isolates were community-acquired (p < 0.001). This suggests established endemicity of ST131 in the Copenhagen community with ongoing local transmission.
Many studies have examined various aspects of E. coli ST131 in diverse localities and clinical contexts (165, 177) . ST131 has two prominent multidrug resistance-associated subclones, one nested within the other, both carrying allele 30 of fimH. H30, the larger subclone, accounts for almost all fluoroquinolone resistance within ST131, whereas H30Rx, a subset within H30, accounts for almost all ST131-associated CTX-M-15 production (10, 11, 91, 101, 178) .
In a Danish survey, ST131 was the single most prevalent clonal group among ESBL-producing E. coli isolates in Copenhagen in 2008-2009, comprising 44 (38%) of the 115 isolates (VI). A similar ST131 fraction among ESBL isolates was found in several international studies (54, 179, 180) and a recent Danish study (181) .
Seven different capsular antigens were identified among the Copenhagen ST131 ESBL isolates (VI), which was the largest diversity of K antigens ever reported for ST131. A significant association between ST131 and K100 was found, and interestingly, most of these isolates were classified initially as having the K2 capsular antigen based on molecular typing criteria (59) . The only other study including K antigens within ST131 was a Norwegian study that identified three different K antigens (K100, K14, and K5) among its nine ST131 isolates (182) . Serogroup O16 ST131 isolates, which in general appear to be relatively uncommon compared with O25b ST131 isolates, have been found recently in Australia, Japan, Korea, France, Spain, United States, Netherlands (11, 99) , and China (183) . Exceptionally, O16 isolates were dominant among the ST131 isolates from China (183) . Paper VI reported two Danish ST131 isolates with serotype O16: K100:H5, which was the first publication of the K antigen status of O16 ST131 isolates. These two isolates' K100 capsular antigen was also the most prevalent K antigen among the (majority) serogroup O25 ST131 isolates reported in paper VI, whereas their H5 flagellar antigen was distinct from the typical H4 antigen of O25b ST131 strains. These two isolates differed considerably from the O25: K100 isolates in a PFGE tree (paper VI), implying a different subspecies phylogenetic background, which is in accordance with other reports (99) .
It is well documented that ST131 is statistically associated with molecularly defined ExPEC status (VI, (13)), which probably partly explains why the ST131 clonal group has been so successful. The finding that nearly all ST131 ESBL isolates in paper VI qualified as ExPEC conflicts with the conventional dogma regarding an inverse relationship between resistance and virulence, especially given the isolates' extensive resistance profiles.
In another molecular epidemiological study (VII), a 43-year archival collection of 128 historic and recent E. coli ST131 isolates (1968-2011) was analyzed for temporal trends involving fitness-associated traits and clonal subsets. Antimicrobial resistance was found to have become progressively more extensive within ST131 over time, particularly over the past decade. This was attributable to the recent appearance of the H30 and H30Rx subclones (91, 101, 178) , with their extensive resistance profiles, rather than a generalized temporal increase in resistance.
Among these study isolates, fluoroquinolone resistance first appeared in 1972 (VII) in a non-H30 isolate. This did not lead to epidemic expansion of the non-H30 subclone, which suggests that fluoroquinolone resistance per se is unlikely to have been the main driver of the (later-appearing) H30 ST131 subclone's epidemiologic success. The chronological sequence of the appearance of the subclones within ST131 is as follows: i) the non-H30 subclone appeared in 1967 (8) ( (178) (101)). The high prevalence of bla CTX-M-15 among ST131 isolates is due primarily to the expansion of the H30Rx subclone, within which bla CTX-M-15 is transmitted vertically (101, 184) .
The prevalence of ExPEC status (13) among ST131 isolates, as reported in paper VII, increased significantly over time and was highest among H30Rx isolates (100%).
Paper VII, the first report of ST131 isolates being EAEC, documented a strong association of biofilm production with EAEC status (p < 0.001). A cluster of eight EAEC ST131 isolates in the PFGE dendrogram (Fig. 2) supported the occurrence of an unrecognized UTI, and possibly also diarrhea, outbreak in the Copenhagen area in 1998-2000 (VII). However, a whole-genome SNP-based (WGS) phylogeny of 155 ST131 isolates comprising 53 archive isolates from the WHO collection (VII) and 102 other historic isolates (101) (Fig. 3) , (method described in (185)), showed many discrepancies compared to PFGE, which is in accordance with the recent report of Price et al. (101) . In contrast to PFGE, the WGS phylogeny showed that all 12 ST131 EAEC isolates fall within the ancestral portion of the H30 cluster, occurring before the emergence of fluoroquinolone resistance, forming two distinct clusters (pink branches in Fig. 3) . One cluster comprised four lactose-negative urine isolates taken within 10 months in 1998. These four urine isolates came from elderly patients admitted to four different departments of the same Copenhagen hospital, suggesting an unrecognized nosocomial outbreak of UTI. The cluster of eight (1998-2004, Fig. 3, pink  branches) , mostly community-source isolates, comprised both fecal isolates from patients with diarrhea (5), plus isolates from urine (2) and the lower respiratory tract (1), indicating that this subclone is possibly able to cause both extraintestinal infections and diarrhea. Four of eight isolates (1999-2000) clustered closely together (differed by no more than 11 SNPs) derived from several geographical areas in Denmark and came from patients with diarrhea (3) and UTI (1) .
All 12 EAEC isolates were Danish except one fecal isolate from Vietnam (2004) (Fig. 3) . The Vietnamese isolate produced CTX-M-27, whereas the other 11 EAEC isolates were non-ESBL-producers. Corresponding to this, 11 of 12 strains were fluoroquinolone-susceptible, although all were gentamicin-resistant. This ST131 EAEC UTI outbreak is reminiscent of the UTI outbreak in Copenhagen caused by an E. coli O78:H10 clonal group in that both fulfilled the molecular criteria for EAEC and contained multiple ExPEC virulence genes (IV). That the O78:H10 outbreak strains' EAEC-associated virulence factors were found to increase uropathogenicity (V) suggests that this may also be true for ST131 EAEC strains.
Although papers VI and VII identified no carbapenemase-producing ST131 isolates among the Copenhagen ESBL 2008-2009 isolates and the WHO collection, multiple other studies from diverse localities have documented this. For example, seven such ST131 isolates (26% of study isolates overall) were reported in 2015 in a Spanish prospective multicenter study of carbapenemase-producing E. coli isolates implicated in clinical infections (186) . Additionally, transfer of an IncN plasmid harboring bla OXA-181 from Morganella morganii to CTX-M-27-producing ST131 E. coli was also reported from the USA in 2015, using isolates from patients with war wound complications (187) . Furthermore, the emergence of the IMP-8 metallo-b-lactamase in E. coli ST131 has been reported in Taiwan (188), a bla KPC ST131 isolate was reported from Australia (189) , and a Chinese study found evidence of both clonal spread and horizontal transfer-mediated dissemination of carbapenemase-producing genes in Shanghai ST131 isolates (190) . Of concern, metallo-betalactamase production was recently found in 28% of clinical ST131 isolates from a hospital setting in India (191) . Similarly, of 20 bla KPCcontaining E. coli isolates identified recently at hospitals in western Pennsylvania, 60% belonged to the epidemic ST131-H30 subclone (192) . This recent emergence of carbapenemase-producing E. coli ST131 is a finding of serious concern, as it poses a public health threat due to its worldwide extent and its involvement of the dominant (and, presumably, more fit) H30 ST131 lineage (167, 192) .
The emergence of plasmid-mediated polymyxin resistance mechanism in Enterobacteriaceae, MCR-1, was recently reported from China (193) and Denmark (194) . The potential transfer of this plasmid into a carbapenemaseproducing ST131 strain conceivably could, depending on the carbapenemase, leave no treatment possibilities for infected patients.
Efficient transmission and intestinal colonization may contribute to the epidemiologic success of the H30Rx subclone of E. coli ST131. In a recent report, approximately onefourth of long-term care facilities residents carried FQ-R ST131 E. coli resembling ST131 clinical isolates (195) . The pulsed-field gel electrophoresis analysis described in paper VII suggested intra-and inter-facility transmission. The identified risk factors suggest that longterm care facility residents who require increased nursing care are at greatest risk for ST131 colonization, possibly due to healthcareassociated transmission. In accordance with this, a Dutch investigation recently revealed an extensive clonal dissemination of blaCTX-M less high-positive E. coli ST131 in a nursing home (196) . An ESBL-producing ST131-H30Rx strain also caused an extensive household outbreak of UTI and intestinal colonization due to ESBLproducing E. coli ST131 (197) .
The increasing prevalence of fluoroquinolone resistance and ESBL production within ST131 (198) was probably promoted by increasing clinical use of fluoroquinolones and cephalosporins (199, 200) . Limited information is available regarding potential changes in the prevalence, epidemiology, and antibiotic susceptibility of ST131 strains in response to antibiotic stewardship efforts (201, 202) . Cefotaxime, dicloxacillin, and clindamycin have been found to promote overgrowth of E. coli ST131 in a mouse intestinal colonization model (203) . Being able to reduce the prevalence or antibiotic resistance of this pandemic clone by antibiotic stewardship could have an enormous impact on public health. Further studies are needed to clarify if antibiotic stewardship can control this pandemic clonal group. ST131 O25 should thus be regarded as a cluster of subclones. The overall temporal increase in resistance within ST131, caused by the emergence of the H30 and H30Rx ST131 subclones, was probably promoted by the increasing use of fluoroquinolones and cephalosporins (199) . The recent epidemiological success of ST131 was probably caused by the distinctive characteristics associated with the H30Rx subclone, i.e., specific ExPEC virulence factors, the K100 capsule (which might serve as a vaccine target), and multidrug resistance, including ESBL production. Rapid cost-effective detection methods for E. coli ST131 are urgently needed, as well as well-designed epidemiological and molecular studies to understand the dynamics of transmission, risk factors, and reservoirs for ST131 (167) .
Likewise, despite stable aggregate virulence scores, temporal shifts in the prevalence of particular virulence factors within ST131 overall have resulted in an increasing prevalence of ExPEC status, a switch from virotype D toward virotypes A and C, and a rising prevalence of capsular antigen K100 (VII). In contrast, the only documented temporal trend within an individual clonal subgroup was the rising prevalence of ExPEC status among the (epidemiologically unsuccessful) non-H30 subset (VII).
CHAPTER 7. CONCLUDING REMARKS AND FUTURE PERSPECTIVES
The two successful ExPEC clonal groups, O15: K52:H1 and ST131-O25B, have both over time increased the overall extent of antimicrobial resistance and specifically the prevalence of fluoroquinolone resistance. The antimicrobial resistance profile of the O15:K52:H1 clonal group has become progressively more extensive, coincident with the appearance of a distinctive minor biotype (C) that has an abundance of antimicrobial resistance markers and diarrheaassociated virulence genes. Similarly, antimicrobial resistance also increased temporally in prevalence and extent in the ST131 clonal group overall, mainly due to the recent appearance of the H30 subclone in 1997 and the H30Rx ST131 subclones in 2002 (101) . In contrast, both the O15:K52:H1 and ST131 clonal groups have maintained a fairly stable total virulence gene content over time, although the prevalence of ExPEC characteristics increased significantly within the ST131 clonal group. All four clonal groups described in this thesis were multidrug-resistant and demonstrated the potential to spread locally or globally. According to one definition (167) , three of the four clonal groups qualify as international multiresistant high-risk clones (Table 3) . A combination of antimicrobial resistance and specific virulence genes and metabolic characteristics likely contributed to these clones' epidemiologic success. Frequent international travel between the western world and Asia (ST131, O117:K1:H7) or Africa (O117:K1:H7) has no doubt contributed to the pandemicity of the ST131 and O17:K1:H7 clonal groups. As for O15:K52:H1, no association with travel has been found. This is also the case for O78:H10, of which only one outbreak of UTI has been reported.
Three ExPEC clonal groups that included EAEC isolates were uniquely reported: O15: K52:H1, O78:H10, and ST131. Papers I, IV, and the present thesis are, to my knowledge, the first reports of EAEC-associated characteristics among any of these three clonal groups. EAEC characteristics likely increase uropathogenicity in E. coli but more research is needed to clarify this.
Future development and implementation of rapid, cost-effective methods would enable laboratories to screen for multiresistant high-risk clones and key virulence genes and pathotypes, such as EAEC. A rapid test would help make individual assessments regarding individualized empirical antibiotics, closer follow-up, and infection control measures in the hospital setting possible. For instance, it might be considered to prolong antibiotic treatment for UTI caused by ST131, as opposed to for instance E. coli O78:H10, but research in this area is needed. No doubt, it would be an advantage if local laboratories could identify EAEC among VTEC isolates rapidly in order to identify hybrid strains that have been shown to have a high mortality. The rising prevalence and extent of antimicrobial resistance among virulent E. coli clones is of great public health concern, and must be dealt with internationally. The obvious solution would be the introduction and implementation of antibiotic stewardship reducing the use of fluoroquinolones and cephalosporins in hospitals, primary health care, and probably also agriculture, especially livestock husbandry. Only limited information on the effect of antibiotic stewardship exists, and future research in this area is of utmost importance.
CHAPTER 8. SUMMARY IN DANISH
Denne disputats opsummerer den historiske og aktuelle status af fire patogene Escherichia coli kloner: O15:K52:H1, O117:K1:H7, O78:H10 og ST131.
E. coli O15:K52:H1 er en succesrig international klon der for arsager extraintestinale infektioner som urinvejsinfektion (UVI), bakteriaemi, Alle fire kloner er multiresistente og har spredt sig lokalt og/eller globalt. Med undtagelse af E. coli O78:H10 opfylder de alle kriterier for en international multiresistent høj-risiko klon. Baggrunden for disse fire kloners epidemiologiske succes skal formentlig søges i kombinationen af multiresistens og specifikke virulensgener. Desuden har hyppige rejser mellem den vestlige verden og Asien samt Afrika har uden tvivl bidraget til udbredelsen af ST131 og O117:K1:H7.
Fremtidig udvikling af hurtige og kosteffektive tests til p avisning af høj-risiko kloner og udvalgte virulensfaktorer i klinisk mikrobiologiske laboratorier ville muliggøre en højere grad af individuel vurdering og behandling af patienter. Den stigende resistens blandt virulente E. coli kloner er af stor betydning for sundhedssektoren verden over, og opfordrer til hurtig politisk handling. En oplagt løsning ville vaere implementeringen af antibiotika politikker p a hospitaler, i primaersektoren og m aske ogs a i landbruget. Der er i øjeblikket kun begraenset erfaring med muligheden for at p avirke udbredelsen af virulente høj-risiko E. coli kloner ved et aendret antibiotikaforbrug, s a intensiv forskning p a dette omr ade er hastende nødvendig.
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